IGF1 and sarcopenia: Other factors, such as chronic inflammation, hyperammonemia, alterations in sex hormones, and insulin-like growth factor-1 signaling may also interfere with the glucose disposal in skeletal muscles and lead to muscle loss (42, 46, 47), which helps to explain the co-existence of sarcopenia with MAFLD.